Targeted therapy with apatinib in a patient with relapsed small cell lung cancer: A case report and literature review.

about

Targeted therapy with apatinib in a patient with relapsed small cell lung cancer: A case report and literature review.

Item

http://www.wikidata.org/entity/Q47640411

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Targeted therapy with apatinib ...... report and literature review.

@en

Targeted therapy with apatinib ...... report and literature review.

@nl

type

Item

label

Targeted therapy with apatinib ...... report and literature review.

@en

Targeted therapy with apatinib ...... report and literature review.

@nl

prefLabel

Targeted therapy with apatinib ...... report and literature review.

@en

Targeted therapy with apatinib ...... report and literature review.

@nl

P1476

Targeted therapy with apatinib ...... report and literature review.

@en

P2093

Chaojie Gong

http://www.w3.org/2001/XMLSchema#string

Jialei Zhang

http://www.w3.org/2001/XMLSchema#string

Jun Zhao

http://www.w3.org/2001/XMLSchema#string

Xiaoling Zhang

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Apatinib (YN968D1) reverses multidrug resistance by inhibiting the efflux function of multiple ATP-binding cassette transporters

Apatinib for molecular targeted therapy in tumor

Targeting angiogenesis in small cell lung cancer

Next-generation EGFR/HER tyrosine kinase inhibitors for the treatment of patients with non-small-cell lung cancer harboring EGFR mutations: a review of the evidence

Tumor angiogenesis

Small cell lung cancer: where do we go from here?

FDA approval summary: crizotinib for the treatment of metastatic non-small cell lung cancer with anaplastic lymphoma kinase rearrangements.

Clinical advances in the development of novel VEGFR2 inhibitors.

Small cell lung cancer: will recent progress lead to improved outcomes?

Semaphorin 4D cooperates with VEGF to promote angiogenesis and tumor progression.

P304

e9259

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

review article

P356

10.1097/MD.0000000000009259

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P5008

ScienceSource

P577

2017-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29390367

http://www.w3.org/2001/XMLSchema#string

P921

lung neoplasm

lung small cell carcinoma

mechanism of action

lung cancer

local neoplasm recurrence

P932

5815779

http://www.w3.org/2001/XMLSchema#string